No evidence for major adverse events related to suspicion of Ebola in France, 2014-2015

Clin Microbiol Infect. 2018 Mar;24(3):310-311. doi: 10.1016/j.cmi.2017.09.004. Epub 2017 Sep 9.

Authors

M Lachâtre¹, M Méchain², M Etienne³, P Gautret⁴, S Matheron¹, M Nahon⁵, H Coignard-Biehler⁶, D Malvy², X Duval¹, P Tattevin⁷

Affiliations

¹ Bichat-Claude Bernard University Hospital, Paris, France.
² Bordeaux University Hospital, Bordeaux, France.
³ Rouen University Hospital, Rouen, France.
⁴ Méditerranée Infection University Hospital Institute, Marseille, France.
⁵ SAMU de Paris, Paris, France.
⁶ Mission COREB Nationale, AP-HP, Paris, France.
⁷ Pontchaillou University Hospital, Rennes, France. Electronic address: [email protected].

PMID: 28899839
DOI: 10.1016/j.cmi.2017.09.004

No abstract available

Publication types

Letter
Multicenter Study

MeSH terms

Adult
Africa
Diagnosis, Differential
Disease Outbreaks
Ebolavirus / isolation & purification
Ebolavirus / pathogenicity
Female
France / epidemiology
Hemorrhagic Fever, Ebola / diagnosis*
Hemorrhagic Fever, Ebola / epidemiology*
Hemorrhagic Fever, Ebola / transmission
Humans
Male
Retrospective Studies
Travel-Related Illness